Human papillomavirus (HPV) vulvitis
Larsen, J.; Petersen, C.S.; Weismann, K.
Ugeskrift for Laeger 152(26): 1911
1990
ISSN/ISBN: 0041-5782 PMID: 2163556 Document Number: 350085
Human papilloma virus vulvitis with flat elements resembling leucoplakia may be diagnosed by application of a 5% acetic acid solution and subsequent biopsy and histological examination. The condition causes irritation with dyspareumia and is so frequent that the diagnosis and initial treatment may be undertaken by the general practitioner.
Document emailed within 1 workday
Related Documents
Hoede, N.; Heidbüchel, U.; Korting, G.W. 1982: Chronic granulomatous vulvitis (Melkersson-Rosenthal vulvitis) Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 33(4): 218-220Brown, B.; Blas, M.M.; Heidari, O.; Carcamo, C.; Halsey, N.A. 2013: Reported changes in sexual behaviour and human papillomavirus knowledge in Peruvian female sex workers following participation in a human papillomavirus vaccine trial International Journal of Std and Aids 24(7): 531-535
Bond, S.M.; Cartmell, K.B.; Lopez, C.M.; Ford, M.E.; Brandt, H.M.; Gore, E.I.; Zapka, J.G.; Alberg, A.J. 2016: Racial and Ethnic Group Knowledge, Perceptions and Behaviors about Human Papillomavirus, Human Papillomavirus Vaccination, and Cervical Cancer among Adolescent Females Journal of Pediatric and Adolescent Gynecology 29(5): 429-435
Moscarini, M.; Lukic, A.; Franco, C. 2004: Anti human papillomavirus vaccine: the checkmate to human papillomavirus? European Journal of Gynaecological Oncology 25(2): 151-156
Townsend, J.S.; Steele, C.Brooke.; Hayes, N.; Bhatt, A.; Moore, A.R. 2017: Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program Journal of Women's Health 26(3): 200-206
Su, L.L. 1987: A study on the relationship between human papillomavirus infection and cervical carcinoma development. Immunoperoxidase localization of papillomavirus antigen in cervical tissue Chinese Medical Journal 100(9): 750-752
Shay, J.W.; Wright, W.E.; Brasiskyte, D.; Van der Haegen, B.A. 1993: E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts Oncogene 8(6): 1407-1413
Camargo, M.; Soto-De Leon, S.C.; Munoz, M.; Sanchez, R.; Peña-Herrera, D.; Pineda-Peña, A.C.; Sussmann, O.; Paez, C.; Perez-Prados, A.; Patarroyo, M.E.; Patarroyo, M.A. 2014: Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia Bmc Cancer 14: 451
Anwar, K.; Nakakuki, K.; Imai, H.; Shiraishi, T.; Inuzuka, M. 1996: Infection of human papillomavirus (HPV) and p53 over-expression in human female genital tract carcinoma Jpma. Journal of the Pakistan Medical Association 46(10): 220-224
Reznikoff, C.A.; Yeager, T.R.; Belair, C.D.; Savelieva, E.; Puthenveettil, J.A.; Stadler, W.M. 1996: Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells Cancer Research 56(13): 2886-2890
Chen, T.M.; Pecoraro, G.; Defendi, V. 1993: Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells Cancer Research 53(5): 1167-1171
Kreiss, J.K.; Kiviat, N.B.; Plummer, F.A.; Roberts, P.L.; Waiyaki, P.; Ngugi, E.; Holmes, K.K. 1992: Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes Sexually Transmitted Diseases 19(1): 54-59
Mbulawa, Z.Z.A.; Johnson, L.F.; Marais, D.J.; Coetzee, D.; Williamson, A.-L. 2013: The impact of human immunodeficiency virus on human papillomavirus transmission in heterosexually active couples Journal of Infection 67(1): 51-58
Vernon, S.D.; Icenogle, J.P.; Johnson, P.R.; Reeves, W.C. 1992: Human papillomavirus, human immunodeficiency virus, and cervical cancer: newly recognized associations? Infectious Agents and Disease 1(6): 319-324
Joshi, S.; Babu, J.M.; Jayalakshmi, D.; Kulkarni, V.; Divate, U.; Muwonge, R.; Gheit, T.; Tommasino, M.; Sankaranarayanan, R.; Pillai, M.R. 2014: Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India Vaccine 32(9): 1079-1085
Melgaço, F.G.; Rosa, M.L.G.; Augusto, E.F.; Haimuri, J.G.S.; Jacintho, C.; Santos, L.S.; Cavalcanti, S.M.B.; Oliveira, L.H.S. 2011: Human papillomavirus genotypes distribution in cervical samples from women living with human immunodeficiency virus Archives of Gynecology and Obstetrics 283(4): 809-817
Zhang, Y.-x.; Xiong, Y.; Gui, X.-e.; Chen, S.-h.; Rong, Y.-p.; Cai, H.-b. 2011: Epidemiologic risk profile of human papillomavirus infections in human immunodeficiency virus-positive Chinese women Japanese Journal of Infectious Diseases 64(5): 411-416
Malik, Z.A.; Hailpern, S.M.; Burk, R.D. 2008: Predictors of seropositivity to human papillomavirus type 53: one of the most prevalent high risk-related cervical human papillomaviruses Viral Immunology 21(3): 371-377
Dames, D.N.; Blackman, E.; Butler, R.; Taioli, E.; Eckstein, S.; Devarajan, K.; Griffith-Bowe, A.; Gomez, P.; Ragin, C. 2014: High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas Plos one 9(1): E85429
Woodworth, C.D.; Waggoner, S.; Barnes, W.; Stoler, M.H.; Dipaolo, J.A. 1990: Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo Cancer Research 50(12): 3709-3715